Deep learning model for assessing survival benefits in hepatocellular carcinoma patients undergoing intra-arterial therapies based on proliferative subtype - Poll - MDSpire

Deep learning model for assessing survival benefits in hepatocellular carcinoma patients undergoing intra-arterial therapies based on proliferative subtype

  • By

  • Fei Cao

  • Chao An

  • Shaolong Li

  • Xiaochun Hu

  • Da Li

  • Jiayu Pan

  • Zhijun Geng

  • Fei Gao

  • Mengxuan Zuo

  • November 19, 2025

  • 0 min

Share

Original Source(s)

Deep learning model for assessing survival benefits in hepatocellular carcinoma patients undergoing intra-arterial therapies based on proliferative subtype

  • by Fei Cao, Chao An, Shaolong Li, Xiaochun Hu, Da Li, Jiayu Pan, Zhijun Geng, Fei Gao, Mengxuan Zuo

  • November 19, 2025

Related Content

HemaContour: explicit parametric contour learning for robust ICH segmentation on non-contrast CT

STD-Net: a spatio-temporal decoupling network for multiphasic liver lesion segmentation and characterization

A clinically validated 3D deep learning approach for quantifying vascular invasion in pancreatic cancer